Back to User profile » Dr Jiliang Li

Papers published by Dr Jiliang Li:

Retraction

WFDC2 Contributes to Epithelial–Mesenchymal Transition (EMT) by Activating AKT Signaling Pathway and Regulating MMP-2 Expression [Retraction]

Chen Y, Huang L, Wang S, Li JL, Li M, Wu Y, Liu T

Cancer Management and Research 2022, 14:1471-1472

Published Date: 20 April 2022

Original Research

WFDC2 contributes to epithelial–mesenchymal transition (EMT) by activating AKT signaling pathway and regulating MMP-2 expression

Chen Y, Huang L, Wang S, Li JL, Li M, Wu Y, Liu T

Cancer Management and Research 2019, 11:2415-2424

Published Date: 27 March 2019